1. MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway
   Guo-Rung You et al, 2022, Cells CrossRef
2. Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer
   Song Wang et al, 2022, Frontiers in Oncology CrossRef
3. Review on the Research Progress of GCLC and GCLM in Tumors
   德转 达, 2022, World Journal of Cancer Research CrossRef
4. BTF4/BTNA3.2 and GCS as Candidate mRNA Prognostic Markers in Epithelial Ovarian Cancer
   Cécile Le Page et al, 2008, Cancer Epidemiology, Biomarkers & Prevention CrossRef